Partners

The right car­go is only the beginning

Nucle­ic acid med­i­cine pro­grams often stall when deliv­ery, for­mu­la­tion, and devel­op­ment plan­ning are han­dled in iso­la­tion. As an inte­grat­ed LNP deliv­ery part­ner, Mirai brings these deci­sions togeth­er ear­li­er, help­ing teams advance cell-spe­cif­ic and extra­hep­at­ic LNP deliv­ery with trans­la­tion in mind.

For part­ners who need deliv­ery to change the equation

  • Car­go is com­pelling but deliv­ery remains the gat­ing variable

  • Pro­gram requires cell-spe­cif­ic or beyond-liv­er delivery

  • Need to reduce hand­off risk across design, deliv­ery, and development

  • Build­ing inter­nal­ly would be too slow or capital-intensive

  • Stan­dard ven­dor mod­els are too nar­row for the pro­gram’s complexity

How com­pa­nies part­ner with Mirai

We can help advance your asset with trans­la­tion in mind from any stage.

  1. 01 Cargo-ready vehicles

    NHP-proven vehi­cles, opti­mized for your needs and designed for devel­op­ment and man­u­fac­tur­ing success.

  2. 02 Emerging access vehicles

    Advance your car­go with vehi­cles that have demon­strat­ed access to high-val­ue extra­hep­at­ic targets.

  3. 03 Novel LNP discovery

    Pio­neer access to nov­el tis­sue fron­tiers together

We co-cre­ate along­side biotechs, opti­miz­ing for end suc­cess at every step

Mirai meets part­ners where they are — adapt­ing to dif­fer­ent dis­ease areas, pro­gram stages, and car­go types while act­ing as an exten­sion of your team through­out the devel­op­ment journey.

The Mirai partnership journey

  • Align

    Align on your pro­gram goals, chal­lenges, and start­ing point. 

  • Strategize

    Build a cus­tomized devel­op­ment strat­e­gy based on your dis­ease area, pro­gram matu­ri­ty, and car­go type.

  • Engineer

    Mirai for­mu­lates and opti­mizes your ther­a­peu­tic using our deliv­ery plat­form, pro­pri­etary tech­nolo­gies, and AI-dri­ven approaches.

  • Evaluate

    Mirai gen­er­ates the data need­ed to assess per­for­mance and guide crit­i­cal devel­op­ment decisions.

  • Advance

    Togeth­er, we trans­late insights into next steps and posi­tion your pro­gram for con­tin­ued progress to the clinic.

Tar­get­ed deliv­ery with devel­op­ment built in

  1. 1

    Expand target access

    We advance cell-specific and extrahepatic delivery across T cells, adipocytes, HSCs, B cells, NK cells, macrophages, endothelial cells, lung, pancreas, and liver.

  2. 2

    Optimize performance

    We use AI/ML-guided design and proprietary in vivo data to improve potency, selectivity, liver detargeting, tolerability, and overall delivery performance.

  3. 3

    Reduce handoff risk

    We integrate cargo design, LNP optimization, process development, analytics, and manufacturing planning from the start to support a more seamless path forward.

Turn delivery into development advantage

Explore a targeted LNP delivery partnership built around your cargo, target, and development goals.

Reach out